Abstract Details
Marie Beaudin, MD
PRESENTER |
Dr. Beaudin has nothing to disclose. |
No disclosure on file | |
Bing-Wen Soong, MD, PhD, FAAN | No disclosure on file |
Jose Luiz Pedroso, MD (Universidade Federal De Sao Paulo) | Dr. Pedroso has nothing to disclose. |
Orlando G. Barsottini, MD, PhD (Universidade Federal de São Paulo) | Dr. Barsottini has nothing to disclose. |
No disclosure on file | |
Shoji Tsuji, MD, PhD (University of Tokyo) | The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd.. |
Jeremy D. Schmahmann, MD, FAAN (Massachusettes General Hospital) | Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. |
Mario Manto, MD, PhD (ULB, Dept of Neurology) | No disclosure on file |
Guy A. Rouleau, MD, PhD, FAAN (Montreal Neurological Institute and Hospital) | Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
Nicolas Dupre, MD, FAAN (CHU de Quebec - U Laval) | Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation. |